These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 2880321

  • 1. 1-Methyl-4-phenylpyridinium (MPP+) but not 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) selectively destroys dopaminergic neurons in cultures of dissociated rat mesencephalic neurons.
    Sanchez-Ramos J, Barrett JN, Goldstein M, Weiner WJ, Hefti F.
    Neurosci Lett; 1986 Dec 12; 72(2):215-20. PubMed ID: 2880321
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mesencephalic dopamine neurons become less sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity during development in vitro.
    Danias P, Nicklas WJ, Ofori S, Shen J, Mytilineou C.
    J Neurochem; 1989 Oct 12; 53(4):1149-55. PubMed ID: 2788714
    [Abstract] [Full Text] [Related]

  • 6. The toxicity of MPTP to dopamine neurons in culture is reduced at high concentrations.
    Friedman L, Mytilineou C.
    Neurosci Lett; 1987 Aug 18; 79(1-2):65-72. PubMed ID: 2890125
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Toxicity of 1-methyl-4-phenylpyridinium for rat dopaminergic neurons in culture: selectivity and irreversibility.
    Michel PP, Dandapani BK, Knusel B, Sanchez-Ramos J, Hefti F.
    J Neurochem; 1990 Apr 18; 54(4):1102-9. PubMed ID: 1968953
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
    Mytilineou C, Cohen G.
    J Neurochem; 1985 Dec 18; 45(6):1951-3. PubMed ID: 3932598
    [Abstract] [Full Text] [Related]

  • 12. Comparison of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium (MPP+) effects on mouse heart norepinephrine.
    Fuller RW, Hemrick-Luecke SK, Robertson DW.
    Biochem Pharmacol; 1988 Sep 01; 37(17):3343-7. PubMed ID: 3135812
    [Abstract] [Full Text] [Related]

  • 13. Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP(+)-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF.
    Park TH, Mytilineou C.
    Brain Res; 1992 Dec 18; 599(1):83-97. PubMed ID: 1362921
    [Abstract] [Full Text] [Related]

  • 14. Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse.
    Perry TL, Yong VW, Jones K, Wall RA, Clavier RM, Foulks JG, Wright JM.
    Neurosci Lett; 1985 Aug 05; 58(3):321-6. PubMed ID: 3876525
    [Abstract] [Full Text] [Related]

  • 15. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ, Heavens RP, McBride CS.
    Brain Res; 1988 Mar 08; 443(1-2):101-16. PubMed ID: 3258784
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms of toxicity and cellular resistance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium in adrenomedullary chromaffin cell cultures.
    Reinhard JF, Carmichael SW, Daniels AJ.
    J Neurochem; 1990 Jul 08; 55(1):311-20. PubMed ID: 1972391
    [Abstract] [Full Text] [Related]

  • 17. Toxic effects of potential environmental neurotoxins related to 1-methyl-4-phenylpyridinium on cultured rat dopaminergic neurons.
    Michel PP, Dandapani BK, Sanchez-Ramos J, Efange S, Pressman BC, Hefti F.
    J Pharmacol Exp Ther; 1989 Feb 08; 248(2):842-50. PubMed ID: 2783974
    [Abstract] [Full Text] [Related]

  • 18. Serotonergic conversion of MPTP and dopaminergic accumulation of MPP+.
    Shen RS, Abell CW, Gessner W, Brossi A.
    FEBS Lett; 1985 Sep 23; 189(2):225-30. PubMed ID: 3876242
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of the tyrosine hydroxylase system by MPTP, 1-methyl-4-phenylpyridinium ion (MPP+) and the structurally related compounds in vitro and in vivo.
    Nagatsu T, Hirata Y.
    Eur Neurol; 1987 Sep 23; 26 Suppl 1():11-5. PubMed ID: 2884110
    [Abstract] [Full Text] [Related]

  • 20. The effect of glia-conditioned medium on dopamine neurons in culture. Modulation of apoptosis, tyrosine hydroxylase expression and 1-methyl-4-phenylpyridinium toxicity.
    Mena MA, Casarejos MJ, García de Yébenes J.
    J Neural Transm (Vienna); 1999 Sep 23; 106(11-12):1105-23. PubMed ID: 10651107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.